Albert D. Mason Inc
BMY icon

Albert D. Mason Inc’s Bristol-Myers Squibb BMY Stock Holding History

Albert D. Mason Inc’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$448K Sell
7,175
-43
-0.6% -$2.72K 0.27% 96
2026
Q2 		$416K Hold
7,218
– – 0.24% 100
2026
Q1 		$438K Sell
7,218
-18
-0.2% -$1.05K 0.28% 91
2025
Q4 		$390K Buy
7,236
+213
+3% +$10.2K 0.26% 99
2025
Q3 		$317K Hold
7,023
– – 0.21% 106
2025
Q2 		$325K Buy
7,023
+60
+0.9% +$2.94K 0.24% 109
2025
Q1 		$425K Sell
6,963
-250
-3% -$14.6K 0.29% 102
2024
Q4 		$408K Buy
7,213
+41
+0.6% +$2.29K 0.27% 108
2024
Q3 		$371K Hold
7,172
– – 0.24% 115
2024
Q2 		$298K Sell
7,172
-35
-0.5% -$1.57K 0.2% 124
2024
Q1 		$391K Buy
7,207
+517
+8% +$26.3K 0.24% 120
2023
Q4 		$343K Hold
6,690
– – 0.23% 123
2023
Q3 		$388K Sell
6,690
-100
-1% -$6.13K 0.28% 120
2023
Q2 		$434K Sell
6,790
-985
-13% -$66K 0.3% 114
2023
Q1 		$539K Sell
7,775
-310
-4% -$21.9K 0.37% 103
2022
Q4 		$582K Hold
8,085
– – 0.42% 100
2022
Q3 		$575K Buy
8,085
+70
+0.9% +$5.08K 0.46% 88
2022
Q2 		$617K Hold
8,015
– – 0.46% 94
2022
Q1 		$585K Buy
8,015
+95
+1% +$6.38K 0.38% 113
2021
Q4 		$494K Buy
7,920
+2,580
+48% +$151K 0.29% 122
2021
Q3 		$316K Buy
5,340
+160
+3% +$10.5K 0.2% 139
2021
Q2 		$346K Buy
5,180
+265
+5% +$17.3K 0.21% 133
2021
Q1 		$310K Buy
4,915
+275
+6% +$17.1K 0.2% 130
2020
Q4 		$288K Buy
+4,640
New +$285K 0.2% 129

Other funds holding BMY

Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 26.62% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $57B AUM 43.56% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return

Albert D. Mason Inc's BMY Position: Q3 2026 in Review

Albert D. Mason Inc reduced its Bristol-Myers Squibb (BMY) stake by 0.6% in Q3 2026, selling an estimated $2.72K and leaving 7,175 shares worth $448K. The position accounts for 0.27% of the portfolio, ranked #96.

Albert D. Mason Inc first reported a position in BMY in Q4 2020 and has held it in 24 quarters since. The position peaked at $617K in Q2 2022. 1,171 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Albert D. Mason Inc held 7,175 shares of Bristol-Myers Squibb worth $448K as of Q3 2026.
  • Albert D. Mason Inc sold 43 Bristol-Myers Squibb shares in Q3 2026, an estimated $2.72K.
  • Bristol-Myers Squibb made up 0.27% of Albert D. Mason Inc's portfolio in Q3 2026, its #96 holding.
  • Albert D. Mason Inc first reported a position in Bristol-Myers Squibb in Q4 2020 and has held it in 24 quarters since.
  • Albert D. Mason Inc's Bristol-Myers Squibb position peaked at $617K in Q2 2022.
  • 1,171 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Albert D. Mason Inc's 13F filing for Q3 2026, filed 27 Oct 2026.